Breaking News Instant updates and real-time market news.

SPLK

Splunk

$123.84

-0.41 (-0.33%)

, HMSY

HMS Holdings

$31.56

-0.3 (-0.94%)

10:24
06/24/19
06/24
10:24
06/24/19
10:24

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Splunk (SPLK) assumed with an Overweight at Piper Jaffray. 2. HMS Holdings (HMSY) initiated with a Sector Weight at KeyBanc. 3. Concert Pharmaceuticals (CNCE) initiated with a Buy at SunTrust. 4. Armstrong World (AWI) resumed with a Buy at Deutsche Bank. 5. Rockwell Medical (RMTI) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SPLK

Splunk

$123.84

-0.41 (-0.33%)

HMSY

HMS Holdings

$31.56

-0.3 (-0.94%)

CNCE

Concert Pharmaceuticals

$11.60

0.7 (6.42%)

AWI

Armstrong World

$97.57

-0.25 (-0.26%)

RMTI

Rockwell Medical

$3.03

0.04 (1.34%)

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

  • 11

    Jul

SPLK Splunk
$123.84

-0.41 (-0.33%)

06/24/19
PIPR
06/24/19
INITIATION
Target $160
PIPR
Overweight
Splunk assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski assumed coverage of Splunk with an Overweight rating and $160 price target, stating that he views it as a "key player" and market leader in the data analytics space, particularly in security and IT operations. He believes it is "still early days" for the company's story and sees a number of growth drivers, Nowinski tells investors.
06/21/19
MZHO
06/21/19
NO CHANGE
Target $155
MZHO
Buy
Splunk poised for free cash flow inflection in fiscal 2021, says Mizuho
Conversations with investors have indicated some confusion with respect to Splunk's financials, including the impact of unbilled amounts, which have spiked over the past few quarters, Mizuho analyst Gregg Moskowitz tells investors in a research note. However, with the vast majority of the transition to renewable contracts "in the rear view mirror," Splunk is poised for a free cash flow inflection in fiscal 2021, contends the analyst. He continues to believe Splunk is very well positioned to continue growing at a high rate. The stock remains one of Moskowitz's top picks with a Buy rating and $155 price target.
06/03/19
MAXM
06/03/19
NO CHANGE
Target $148
MAXM
Buy
Splunk price target lowered to $148 from $159 at Maxim
Maxim analyst Nehal Chokshi lowered his price target on Splunk to $148 to reflect his reduced expectations for free cash flows given the company's cloud acceleration drive. The analyst also keeps his Buy rating on the shares and believes the impact of acceleration will normalize "once Cloud reaches stabilized levels."
06/07/19
GSCO
06/07/19
INITIATION
Target $119
GSCO
Neutral
Splunk initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Christopher Merwin started Splunk with a Neutral rating and $119 price target.
HMSY HMS Holdings
$31.56

-0.3 (-0.94%)

06/24/19
KEYB
06/24/19
INITIATION
KEYB
Sector Weight
HMS Holdings initiated with a Sector Weight at KeyBanc
KeyBanc analyst Donald Hooker started coverage of HMS Holdings with a Sector Weight as a potential way for investors to participate in the increasing use of artificial intelligence and robotic process automation to reduce payment errors and fraud in U.S. healthcare and improve population health management. The analyst says that HMS Holdings generates about 80% of its revenue from Medicaid programs, further giving the company a somewhat recession resistant profile, but notes that the stock seems fairly valued at current levels.
06/24/19
ADAM
06/24/19
NO CHANGE
Target $39
ADAM
Buy
HMS Holdings' recent weakness overdone, says Canaccord
Canaccord analyst Richard Close said he believes the recent weakness in HMS Holdings (HMSY) shares is overdone. The weakness was attributed to reports UnitedHealth (UNH) will be buying Equian, a payment integrity services provider. The analyst believes the pullback was based on fears of increased competition and potential risk that HMS will lose UnitedHealth as a customer. He said although both provide integrity services to healthcare, Equian does not provide COB services, which accounted for 66.4% of HMS's revenue. As a result, he does not believe this transaction should raise any concerns. Close reiterated his Buy rating and $39 price target on HMS Holdings shares.
06/21/19
CANT
06/21/19
NO CHANGE
CANT
Overweight
HMS Holdings selloff on Equian deal report overdone, says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper noted HMS Holdings (HMSY) shares are lower, which he believes is due to media reports that UnitedHealth (UNH) will acquire privately-held Equian, which is focused primarily on payment integrity. Halper notes that payment integrity accounts for about 19% of HMS' total revenue and said any potential transaction could result in health plans switching from Equian to HMS over time. The analyst, who views the selloff as overdone, keeps an Overweight rating on HMS Holdings shares.
04/17/19
GUGG
04/17/19
INITIATION
Target $33
GUGG
Buy
HMS Holdings initiated with a Buy at Guggenheim
Guggenheim analyst Vikram Kesavabhotla started HMS Holdings with a Buy rating and $33 price target. The analyst believes the company's margin expansion is in the "early innings." Achievable guidance and consensus estimate range has created an attractive risk/reward opportunity, Kesavabhotla tells investors in a research note. He also believes HMS has strategic value, which should help limit downside in the shares.
CNCE Concert Pharmaceuticals
$11.60

0.7 (6.42%)

06/13/19
06/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delphi Technologies (DLPH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying new CEO Rick Dauch's more operationally focused initiatives should drive "idiosyncratic" margin and free cash flow expansion into 2020. 2. Williams-Sonoma (WSM) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying following the meetings, and based on more upbeat than expected results from peer RH (RH), he has a higher degree of confidence about both the company's near-term results and its long-term options. 3. Concert Pharmaceuticals (CNCE) upgraded to Buy from Neutral at Janney Montgomery Scott with analyst Esther Hong saying CTP-692 broadens Concert 's clinical pipeline. 4. CenterPoint Energy (CNP) upgraded to Buy on valuation at BofA/Merrill with analyst Julien Dumoulin-Smith citing "compelling" valuation. 5. HCP (HCP) upgraded to Outperform from Market Perform at Raymond James with analyst Jonathan Hughes citing relative valuation and size, development contributions visibility, and accelerating same-store NOI growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/19
HCWC
06/13/19
NO CHANGE
Target $29
HCWC
Buy
Concert Pharmaceuticals price target raised to $29 from $26 at H.C. Wainwright
H.C. Wainwright analyst Andrew Fein raised his price target for Concert Pharmaceuticals to $29 from $26 saying the safety data of CTP-692 "cleared a major hurdle." The analyst believes a sizable portion of the development risk for CTP-692 is related to safety and dose in clinical trials. As such, the Phase 1 results reported yesterday "cleared a major roadblock, and significantly de-risked the molecule risk," Fein tells investors in a research note. He reiterates a Buy rating on Concert Pharmaceuticals.
06/24/19
RHCO
06/24/19
INITIATION
Target $30
RHCO
Buy
SunTrust starts Concert with Buy rating and $30 price target
As previously reported, SunTrust analyst Joon Lee initiated Concert Pharmaceuticals with a Buy rating and $30 price target. In a research note to investors, Lee contends that Concert's CTP-692 is one of the most differentiated and promising, yet under-appreciated drugs in development for schizophrenia. The analyst thinks the drug's period of remaining under the market's radar will be short-lived.
06/24/19
RHCO
06/24/19
INITIATION
Target $30
RHCO
Buy
Concert Pharmaceuticals initiated with a Buy at SunTrust
SunTrust analyst Joon Lee initiated Concert Pharmaceuticals with a Buy and $30 price target.
AWI Armstrong World
$97.57

-0.25 (-0.26%)

05/01/19
ZELM
05/01/19
DOWNGRADE
ZELM
Sell
Armstrong World downgraded to Sell from Hold at Zelman
06/19/19
LBOW
06/19/19
NO CHANGE
LBOW
Neutral
Armstrong World estimates raised following positive checks at Longbow
Longbow analyst Garik Shmois raised his Q2 estimates for Armstrong World above consensus after his ceiling channel checks, stating that demand appears to be tracking ahead of his previous 1% growth forecast. He continue to hear backlogs remain healthy into the second half, added Shmois, who keeps a Neutral rating on Armstrong shares but said he "skews positive" on its solid earnings growth outlook. The company "looks well on its way to the mid- to upper-end of guidance" based on these checks and a strong Q1, added Shmois.
06/18/19
RHCO
06/18/19
NO CHANGE
Target $109
RHCO
Buy
Armstrong World price target raised to $109 from $95 at SunTrust
SunTrust analyst Keith Hughes raised his price target on Armstrong World to $109 and kept his Buy rating, saying that while the company's relative faster growth has made the stock a "best performer" in his coverage universe, there is more room to grow its valuation. The analyst cites the company's "group leading margins" and believes that Armstrong World possesses the characteristics of higher multiple companies, with organic growth rate trending toward the higher end of his coverage group.
06/24/19
DBAB
06/24/19
INITIATION
Target $107
DBAB
Buy
Armstrong World resumed with a Buy at Deutsche Bank
Deutsche Bank analyst Nishu Sood resumed coverage of Armstrong World with a Buy rating and $107 price target, telling investors that Armstrong's story "has developed as well as we could have expected and then some" since the last note published on Armstrong in late 2017. Previously, Sood had said he thought the company had a compelling growth story developing in its Architectural Specialties business that would be more appreciated as investors got past concerns about the mineral fiber and European businesses.
RMTI Rockwell Medical
$3.03

0.04 (1.34%)

03/18/19
IFSG
03/18/19
UPGRADE
IFSG
Strong Buy
Rockwell Medical upgraded to Strong Buy from Outperform at IFS Securities
06/24/19
PIPR
06/24/19
INITIATION
Target $10
PIPR
Overweight
Rockwell Medical initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Christopher Raymond initiated Rockwell Medical with an Overweight rating and $10 price target, citing his view that that the company's new management team is "significantly more qualified" and can carve out a significant position in the renal space for Triferic IV with an approval and launch expected in 2020. He thinks the stock "could triple" if his 2020 revenue estimate of $90M and his 2022 revenue estimate of $274M "prove even directionally correct," Raymond tells investors.
06/19/19
IFSG
06/19/19
DOWNGRADE
Target $11
IFSG
Outperform
Rockwell Medical downgraded to Outperform from Strong Buy at IFS Securities
IFS Securities analyst David Bouchey downgraded Rockwell Medical to Outperform from Strong Buy with an unchanged price target of $11. The analyst sees both positive and negative effects from the company's 5.8M share offering. However, he believes Rockwell's long-term fundamentals are "highly positive."
05/13/19
HCWC
05/13/19
INITIATION
Target $11
HCWC
Buy
Rockwell Medical initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Rockwell Medical with a Buy rating and $11 price target. The analyst calls Rockwell an emerging biopharmaceutical company focused on the hemodialysis market involving patients with end-stage renal disease.

TODAY'S FREE FLY STORIES

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

, AMD

AMD

$29.55

-2.35 (-7.37%)

04:55
08/25/19
08/25
04:55
08/25/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

AMD

AMD

$29.55

-2.35 (-7.37%)

ANET

Arista Networks

$223.35

-3.84 (-1.69%)

CHKP

Check Point

$106.84

-2.36 (-2.16%)

CSCO

Cisco

$46.65

-1.55 (-3.22%)

EQIX

Equinix

$549.81

-4.27 (-0.77%)

FLEX

Flex

$9.72

-0.54 (-5.26%)

INTC

Intel

$44.97

-1.79 (-3.83%)

NVDA

Nvidia

$162.51

-8.93 (-5.21%)

OTEX

OpenText

$38.54

-0.57 (-1.46%)

PYPL

PayPal

$106.08

-2.66 (-2.45%)

RNG

RingCentral

$141.50

-0.86 (-0.60%)

SQ

Square

$61.65

-3 (-4.64%)

STX

Seagate

$46.96

-0.62 (-1.30%)

TWLO

Twilio

$127.90

-2.585 (-1.98%)

V

Visa

$175.24

-4.91 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

NFLX

Netflix

$291.40

-5.47 (-1.84%)

, DIS

Disney

$131.70

-4.37 (-3.21%)

11:55
08/24/19
08/24
11:55
08/24/19
11:55
Periodicals
Football season is back, key moment for TV future, Barron's says »

On Sept. 5, when the…

NFLX

Netflix

$291.40

-5.47 (-1.84%)

DIS

Disney

$131.70

-4.37 (-3.21%)

FOXA

Fox Corp.

$31.76

-1.29 (-3.90%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

CBS

CBS

$41.39

-2.06 (-4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

AAPL

Apple

$202.73

-9.82 (-4.62%)

, AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

09:03
08/24/19
08/24
09:03
08/24/19
09:03
Periodicals
Costco the most 'woke' company out there, Barron's says »

Earlier this week, the…

AAPL

Apple

$202.73

-9.82 (-4.62%)

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

BLK

BlackRock

$407.29

-11.55 (-2.76%)

WMT

Walmart

$110.83

-1.07 (-0.96%)

COST

Costco

$274.16

-5.7 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 25

    Sep

  • 03

    Oct

  • 27

    Oct

  • 13

    Nov

  • 14

    Nov

MMM

3M

$155.84

-5.04 (-3.13%)

08:58
08/24/19
08/24
08:58
08/24/19
08:58
Periodicals
3M stock still not looking like a bargain, Barron's says »

3M shares are down by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ULTA

Ulta Beauty

$322.34

-12.5 (-3.73%)

08:56
08/24/19
08/24
08:56
08/24/19
08:56
Periodicals
Ulta Beauty bucking downbeat retail trends, Barron's says »

Ulta Beauty has been one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 25

    Sep

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$42.47

-1.29 (-2.95%)

08:49
08/24/19
08/24
08:49
08/24/19
08:49
Periodicals
Roku working for investors, Barron's says »

The streaming war…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

DIS

Disney

$131.70

-4.37 (-3.21%)

NFLX

Netflix

$291.40

-5.47 (-1.84%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

ROKU

Roku

$137.77

-1.35 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

NSRGY

Nestle

$0.00

(0.00%)

08:44
08/24/19
08/24
08:44
08/24/19
08:44
Periodicals
Nestle stock looking appetizing after big gain, Barron's says »

Nestle is having a great…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$291.40

-5.47 (-1.84%)

, DIS

Disney

$131.70

-4.37 (-3.21%)

08:39
08/24/19
08/24
08:39
08/24/19
08:39
Periodicals
Football season is back, key moment for TV future, Barron's says »

On Sept. 5, when the…

NFLX

Netflix

$291.40

-5.47 (-1.84%)

DIS

Disney

$131.70

-4.37 (-3.21%)

FOXA

Fox Corp.

$31.76

-1.29 (-3.90%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$42.47

-1.29 (-2.95%)

CBS

CBS

$41.39

-2.06 (-4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 27

    Oct

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

, FDX

FedEx

$151.94

-6.17 (-3.90%)

08:05
08/24/19
08/24
08:05
08/24/19
08:05
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

FDX

FedEx

$151.94

-6.17 (-3.90%)

UPS

UPS

$111.29

-3.91 (-3.39%)

F

Ford

$8.76

-0.27 (-2.99%)

GM

General Motors

$36.06

-1.19 (-3.19%)

DDAIF

Daimler AG

$0.00

(0.00%)

HMC

Honda

$22.90

-0.32 (-1.38%)

TM

Toyota

$127.94

-1.69 (-1.30%)

VWAGY

Volkswagen

$0.00

(0.00%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

FB

Facebook

$177.69

-4.39 (-2.41%)

TWTR

Twitter

$41.01

-1.16 (-2.75%)

GOOGL

Alphabet Class A

$1,154.66

-35.75 (-3.00%)

GOOG

Alphabet

$1,151.72

-36.81 (-3.10%)

ADM

Archer Daniels

$37.44

-0.48 (-1.27%)

REGI

Renewable Energy

$11.65

0.61 (5.53%)

GPRE

Green Plains

$7.34

-0.68 (-8.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 17

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 13

    Nov

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

, AMD

AMD

$29.55

-2.35 (-7.37%)

04:55
08/24/19
08/24
04:55
08/24/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

AMD

AMD

$29.55

-2.35 (-7.37%)

ANET

Arista Networks

$223.35

-3.84 (-1.69%)

CHKP

Check Point

$106.84

-2.36 (-2.16%)

CSCO

Cisco

$46.65

-1.55 (-3.22%)

EQIX

Equinix

$549.81

-4.27 (-0.77%)

FLEX

Flex

$9.72

-0.54 (-5.26%)

INTC

Intel

$44.97

-1.79 (-3.83%)

NVDA

Nvidia

$162.51

-8.93 (-5.21%)

OTEX

OpenText

$38.54

-0.57 (-1.46%)

PYPL

PayPal

$106.08

-2.66 (-2.45%)

RNG

RingCentral

$141.50

-0.86 (-0.60%)

SQ

Square

$61.65

-3 (-4.64%)

STX

Seagate

$46.96

-0.62 (-1.30%)

TWLO

Twilio

$127.90

-2.585 (-1.98%)

V

Visa

$175.24

-4.91 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.